Takhzyro 150 MG
Ended Awarded
- Contract number
- 36C24525N1012
- Awardee
-
Takeda Pharmaceuticals America, Inc. UEI DDEVYUAXJ624
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $36,984
Award facts
- Contract value 100% obligated
- $36,984.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Brooks, KY 40109, USA
Award details come from SAM.gov/FPDS.
About this award
This federal contract award is for the pharmaceutical product TAKHZYRO 150 MG, awarded to Takeda Pharmaceuticals America Inc., a subsidiary of the global biopharmaceutical company Takeda Pharmaceutical Company Limited. The contract has a ceiling value of $36,984.28 and was awarded on September 18, 2025, with an ultimate completion date of September 23, 2025.
The contract was awarded under the General Services Administration (GSA) Pharmaceuticals and Drugs Schedule (FSS-61-IB) and does not have a set-aside designation. Takeda Pharmaceuticals America Inc. is a foreign-owned, for-profit manufacturer of pharmaceutical goods, specializing in rare disease, hematology, immunology, oncology, and critical medical treatments. The company has a significant Blanket Purchase Agreement (BPA) with the Department of Veterans Affairs (VA) National Acquisition Center, valued at $131,039,520.00, effective from July 15, 2025, to July 14, 2026, for the procurement of various critical medications.
Quick answers
Who was awarded contract 36C24525N1012?
36C24525N1012 was awarded to Takeda Pharmaceuticals America, Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on September 18, 2025.
How much is contract 36C24525N1012 worth?
The government has obligated $36,984 on 36C24525N1012.
Is contract 36C24525N1012 an order under another contract?
Yes. 36C24525N1012 is a delivery order under V797D50492, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24525N1012 competed?
The extent of competition for 36C24525N1012 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award